Orgenesis Inc. Files Form 8-K
Ticker: ORGS · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $1.03, $1.50, $2.00, $2.3 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-event
TL;DR
Orgenesis Inc. filed an 8-K on March 3, 2024, detailing material agreements and equity sales.
AI Summary
Orgenesis Inc. announced on March 3, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. This filing is a current report on Form 8-K.
Why It Matters
This 8-K filing indicates significant corporate events and potential changes for Orgenesis Inc., requiring investor attention.
Risk Assessment
Risk Level: medium — Form 8-K filings often contain material information that can impact stock price, necessitating careful review.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- March 3, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-38416 (identifier) — Commission File Number
- 98-0583166 (identifier) — IRS Employer Identification No.
- 20271 Goldenrod Lane, Germantown, MD 20876 (address) — Principal executive offices
FAQ
What specific material definitive agreement did Orgenesis Inc. enter into?
The filing does not specify the details of the material definitive agreement, only that one was entered into on March 3, 2024.
What was the nature of the unregistered sales of equity securities?
The filing mentions unregistered sales of equity securities but does not provide specific details regarding the number of shares, price, or purchasers.
What are the 'Other Events' reported in this 8-K?
The filing indicates 'Other Events' were reported but does not list them explicitly in the provided text.
When was the earliest event reported in this Form 8-K?
The earliest event reported in this Form 8-K occurred on March 3, 2024.
Where is Orgenesis Inc. incorporated and what is its principal executive office address?
Orgenesis Inc. is incorporated in Nevada and its principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.
Filing Stats: 1,079 words · 4 min read · ~4 pages · Grade level 10.7 · Accepted 2024-03-07 12:11:22
Key Financial Figures
- $0.0001 — f the Company's common stock, par value $0.0001 per share (the "Common Stock"), at a pu
- $1.03 — "Common Stock"), at a purchase price of $1.03 per share (the "Shares") and warrants t
- $1.50 — of Common Stock at an exercise price of $1.50 per share and warrants to purchase up t
- $2.00 — of Common Stock at an exercise price of $2.00 per share (collectively, the "Warrants"
- $2.3 million — eceived gross proceeds of approximately $2.3 million before deducting related offering expen
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex4-1.htm (EX-4.1) — 79KB
- ex4-2.htm (EX-4.2) — 77KB
- ex10-1.htm (EX-10.1) — 713KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-009178.txt ( ) — 1186KB
- orgs-20240303.xsd (EX-101.SCH) — 3KB
- orgs-20240303_lab.xml (EX-101.LAB) — 33KB
- orgs-20240303_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: March 6, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary